Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Pointsharp on the acquisition of Vemendo
Mandate

Vinge advises Main Capital and Pointsharp on the acquisition of Vemendo

May 07, 2025 M&A Intellectual Property Data protection and processing of personal data

Vinge has advised Pointsharp International AB, an identity and access management software provider, on its acquisition of Vemendo AB (“Vemendo”). The strategic acquisition complements Pointsharp well and is in line with the company's growth strategy in the European identity and access management market.

Vemendo provides software for identity management, user provisioning and lifecycle management which enables user information to be up-to-date, users to securely log in to multiple networks or systems, and identity information to be easily tracked within the organisation.

Vinge's team consisted of Filip Öhrner and Alex Forsberg (M&A), Arvid Axelryd (IP) and Martin Boström (GDPR).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025